ES2125802A1 - Pharmaceutical composition for the oral administration of iron in piglets, and procedure for the production thereof - Google Patents

Pharmaceutical composition for the oral administration of iron in piglets, and procedure for the production thereof

Info

Publication number
ES2125802A1
ES2125802A1 ES09601586A ES9601586A ES2125802A1 ES 2125802 A1 ES2125802 A1 ES 2125802A1 ES 09601586 A ES09601586 A ES 09601586A ES 9601586 A ES9601586 A ES 9601586A ES 2125802 A1 ES2125802 A1 ES 2125802A1
Authority
ES
Spain
Prior art keywords
iron
until
procedure
methionate
piglets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09601586A
Other languages
Spanish (es)
Other versions
ES2125802B1 (en
Inventor
I Mas Salvador Bou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DIVASA FARMAVIC S A
Original Assignee
DIVASA FARMAVIC S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DIVASA FARMAVIC S A filed Critical DIVASA FARMAVIC S A
Priority to ES9601586A priority Critical patent/ES2125802B1/en
Publication of ES2125802A1 publication Critical patent/ES2125802A1/en
Application granted granted Critical
Publication of ES2125802B1 publication Critical patent/ES2125802B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

It includes (i) oily carrier excipients between 50 and 70%, (ii) gelling agents of between 1 and 4%, and (iii) iron methionate of between 30 and 80%, in such a way that the composition has between 50 and 100 mg of Fe/ml and a viscosity of between 500 and 1,500 cps. It also includes (iv) preservatives of between 0.2 and 0.6%, and (v) aromas between of 0.3 and 0.5%. The procedure involves adding oily excipients (i) into a suitable reactor adding gelling agents (ii) while stirring heating until the above mixture melts completely, stirring slowly leaving to cool until a transparent gel forms at ambient temperature, adding iron methionate with vigorous stirring until the product is homogenized and passing through a refiner until a suitable texture is obtained. Use of the composition by the oral route to prevent the appearance of iron deficiency anaemia.
ES9601586A 1996-07-16 1996-07-16 PHARMACEUTICAL COMPOSITION FOR THE ORAL ADMINISTRATION OF IRON IN PIGLETS AND PROCEDURE FOR THEIR OBTAINING. Expired - Fee Related ES2125802B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9601586A ES2125802B1 (en) 1996-07-16 1996-07-16 PHARMACEUTICAL COMPOSITION FOR THE ORAL ADMINISTRATION OF IRON IN PIGLETS AND PROCEDURE FOR THEIR OBTAINING.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9601586A ES2125802B1 (en) 1996-07-16 1996-07-16 PHARMACEUTICAL COMPOSITION FOR THE ORAL ADMINISTRATION OF IRON IN PIGLETS AND PROCEDURE FOR THEIR OBTAINING.

Publications (2)

Publication Number Publication Date
ES2125802A1 true ES2125802A1 (en) 1999-03-01
ES2125802B1 ES2125802B1 (en) 1999-11-16

Family

ID=8295512

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9601586A Expired - Fee Related ES2125802B1 (en) 1996-07-16 1996-07-16 PHARMACEUTICAL COMPOSITION FOR THE ORAL ADMINISTRATION OF IRON IN PIGLETS AND PROCEDURE FOR THEIR OBTAINING.

Country Status (1)

Country Link
ES (1) ES2125802B1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070350A (en) * 1964-12-04 1967-06-01 Grace W R & Co Improvements in or relating to nutritional compositions for suckling pigs
GB1322102A (en) * 1970-03-13 1973-07-04 Fisons Ltd Treatment of iron deficiency in piglets
WO1993013783A1 (en) * 1992-01-20 1993-07-22 Holm Christensen Boerge An iron-containing composition for the prevention of anaemia and a method for producing the composition
EP0634174A1 (en) * 1993-07-13 1995-01-18 Takeda Chemical Industries, Ltd. Antianemic composition for veterinary use

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070350A (en) * 1964-12-04 1967-06-01 Grace W R & Co Improvements in or relating to nutritional compositions for suckling pigs
GB1322102A (en) * 1970-03-13 1973-07-04 Fisons Ltd Treatment of iron deficiency in piglets
WO1993013783A1 (en) * 1992-01-20 1993-07-22 Holm Christensen Boerge An iron-containing composition for the prevention of anaemia and a method for producing the composition
EP0634174A1 (en) * 1993-07-13 1995-01-18 Takeda Chemical Industries, Ltd. Antianemic composition for veterinary use

Also Published As

Publication number Publication date
ES2125802B1 (en) 1999-11-16

Similar Documents

Publication Publication Date Title
ES2173400T3 (en) COMPOSITIONS CONTAINING CINC FOR ORAL ADMINISTRATION THAT INCLUDE A COPPER COMPOUND AND AN AMINO ACID.
IL141881A0 (en) Hydrocolloid confectionery
EP0283713A3 (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
IL147044A0 (en) Gelled nutritional composition and process
LT2001041A (en) Stable liquid formulations of botulinum toxin
ZA949309B (en) Composition for the production of therapeutic products in vivo
DE69806820D1 (en) CALORIOUS NUTRITIONAL COMPOSITION
PL300194A1 (en) Interferon conjugate, method of obtaining same and pharmaceutical composition containing it
HUT41759A (en) Process for producing new pharmaceutical composition containing ipriflavone in form of cyclodextrine inclusion complex
ATE208615T1 (en) METHOD FOR PRODUCING FREEZE-DRIED MEDICINAL DOSAGE FORMS
ATE292455T1 (en) COMPOSITIONS CONTAINING FAT-SOLUBLE VITAMINS
CA2258868A1 (en) Dietary supplements containing calcium citrate and carbonyl iron
IL103213A (en) Medicaments for treating gastrointestinal disorders containing ranitidine bismuth citrate together with certain helicobacter pylori-inhibiting antibiotics
HU9603440D0 (en) Process and apparatus for making rapidly dissolving dosage units and product therefrom
UA60352C2 (en) synthetic polysaccharides, a method for preparing thereof and pharmaceutical composition containing them
GB8506027D0 (en) Pharmaceutical & dietary compositions
PT76247B (en) Process for preparing antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes and of pharmaceutical compositions containing the same
NZ506383A (en) A modified cream product comprising a gelling agent
MD970269A (en) Clavulanates
IL74138A0 (en) Indolophenanthridines,their production and pharmaceutical compositions containing them
ES2125802B1 (en) PHARMACEUTICAL COMPOSITION FOR THE ORAL ADMINISTRATION OF IRON IN PIGLETS AND PROCEDURE FOR THEIR OBTAINING.
EP0275526A3 (en) Composition for administration through a body cavity
BG104880A (en) Medicamentous preparation for multiple sclerosis treatment
DE3473826D1 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
GB8804188D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19990301

Kind code of ref document: A1

Effective date: 19990301

FD2A Announcement of lapse in spain

Effective date: 20161026